α,β-Methylene-ATP

Catalog No. :
ACIXRW942
CAS No. :
7292-42-4
Molecular Formula :
C11H18N5O12P3
Molecular Weight :
505.21

IUPAC Name:(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic phosphoric anhydride

α,β-Methylene-ATP structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameα,β-Methylene-ATP
IUPAC Name(((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic phosphoric anhydride
Molecular FormulaC11H18N5O12P3
Molecular Weight505.21
SMILESO=P(O)(OP(CP(O)(OC[C@H]1O[C@@H](N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O)=O)(O)=O)O
InChI KeyCAWZRIXWFRFUQB-IOSLPCCCSA-N
Synonymalpha,beta-Methyleneadenosine 5'-triphosphate | diphosphomethylphosphonic acid adenosyl ester | alpha,beta-meATP | [3H]alphabeta-meATP | alpha,beta-Methylene ATP
CAS No.7292-42-4
PubChem CID91557

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIXRW942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXRW942 route product structure diagram
    ACIXRW9427292-42-4
Inquiry

2. ACIXRW942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCQCK608 route compound structure diagram
    ACCQCK6081306-06-5
  4. Then
  5. ACIXRW942 route product structure diagram
    ACIXRW9427292-42-4
Inquiry

Comments (0)